Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Borkowsky

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
The Pediatric Infectious Disease Journal|December 1, 1992
Varicella does not appear to be a cofactor for human immunodeficiency virus infection in childrenJ E Aronson, G McSherry, L Hoyt, et al.
AIDS (London, England)|January 1, 1997
CD8+ T-cell-mediated suppression of HIV replication in the first year of life: association with lower viral load and favorable early survivalH Pollack, M X Zhan, J T Safrit, et al.
AIDS (London, England)|September 1, 1995
The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmissionD T Dunn, C D Brandt, A Krivine, et al.
The New England Journal of Medicine|April 21, 1991
A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study GroupR E McKinney, M A Maha, E M Connor, et al.
AIDS (London, England)|January 12, 2000
Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected childrenS M Essajee, M Kim, C Gonzalez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2001
Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected womenC K Cunningham, D W Wara, M Kang, et al.
The Journal of Infectious Diseases|July 7, 2000
The impact of early initiation of highly active antiretroviral therapy on the human immunodeficiency virus type 1-specific CD8 T cell response in childrenH M Spiegel, R Chandwani, M E Sheehy, et al.
Journal of Virology|January 7, 2000
Human immunodeficiency virus type 1- and cytomegalovirus-specific cytotoxic T lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4(+) T cellsH M Spiegel, G S Ogg, E DeFalcon, et al.
JAMA|February 5, 2000
Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study TeamS A Nachman, K Stanley, R Yogev, et al.
The Journal of Infectious Diseases|July 9, 1999
Changes in frequency of HIV-1-specific cytotoxic T cell precursors and circulating effectors after combination antiretroviral therapy in childrenH M Spiegel, E DeFalcon, G S Ogg, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
The Pediatric Infectious Disease Journal|December 1, 1992
Varicella does not appear to be a cofactor for human immunodeficiency virus infection in childrenJ E Aronson, G McSherry, L Hoyt, et al.
AIDS (London, England)|January 1, 1997
CD8+ T-cell-mediated suppression of HIV replication in the first year of life: association with lower viral load and favorable early survivalH Pollack, M X Zhan, J T Safrit, et al.
AIDS (London, England)|September 1, 1995
The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmissionD T Dunn, C D Brandt, A Krivine, et al.
The New England Journal of Medicine|April 21, 1991
A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study GroupR E McKinney, M A Maha, E M Connor, et al.
AIDS (London, England)|January 12, 2000
Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected childrenS M Essajee, M Kim, C Gonzalez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2001
Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected womenC K Cunningham, D W Wara, M Kang, et al.
The Journal of Infectious Diseases|July 7, 2000
The impact of early initiation of highly active antiretroviral therapy on the human immunodeficiency virus type 1-specific CD8 T cell response in childrenH M Spiegel, R Chandwani, M E Sheehy, et al.
Journal of Virology|January 7, 2000
Human immunodeficiency virus type 1- and cytomegalovirus-specific cytotoxic T lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4(+) T cellsH M Spiegel, G S Ogg, E DeFalcon, et al.
JAMA|February 5, 2000
Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study TeamS A Nachman, K Stanley, R Yogev, et al.
The Journal of Infectious Diseases|July 9, 1999
Changes in frequency of HIV-1-specific cytotoxic T cell precursors and circulating effectors after combination antiretroviral therapy in childrenH M Spiegel, E DeFalcon, G S Ogg, et al.
Pageof 12